ASPI — ASP Isotopes Inc. Common Stock
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
Company profile
- Sector: Basic Materials
- Industry: Chemicals
- Country: US
- Exchange: NASDAQ
- Employees: 136
Latest SEC filings for ASPI
- SCHEDULE 13D — 2026-10-08
- 8-K — 2026-09-08
- 8-K — 2026-08-20
- 8-K — 2026-08-20
- 8-K — 2026-08-18
- 10-Q — 2026-08-14
- 8-K — 2026-08-06
- 8-K — 2026-08-05
- 8-K — 2026-08-04
- 8-K — 2026-07-30
Latest ASPI news
- — ASP Isotopes jumps as QLE signs South African HALEU JV framework (seekingalpha_market)
- — ASP Isotopes (NASDAQ:ASPI) Director Robert John Andrew Ryan Acquires 15,000 Shares of Stock
- — Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- — Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders? (prnewswire.com)
Educational tool only — not investment advice.